Is Tibet Weixinkang Medicine stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Tibet Weixinkang Medicine pays dividends. Last time was Tuesday 2nd of July 2024 where the investors holding the stock on Tuesday 2nd of July 2024 were paid CNY0.285 per share. Over the last 7 times between 2018 and 2024, Tibet Weixinkang Medicine has paid CNY0.955 with an average of CNY0.14 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Tibet Weixinkang Medicine 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY12.34, you would have made a loss of CNY-4.75 per share or -38.49%
Yes, the average daily trading liquidity for Tibet Weixinkang Medicine is CNY2.97 million. You should therefore be able to get in and out of your positions relatively fast.
Tibet Weixinkang Medicine has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 47.73, the company's ability to pay off the debt is good. Tibet Weixinkang Medicine has a good net profit margin of 19.28% and should have high tolerances against inflation.
We have calculated the inflation risk for Tibet Weixinkang Medicine to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.